Literature DB >> 10340767

BQ788, an endothelin ET(B) receptor antagonist, attenuates stab wound injury-induced reactive astrocytes in rat brain.

Y Koyama1, M Takemura, K Fujiki, N Ishikawa, Y Shigenaga, A Baba.   

Abstract

Endothelins (ETs) are suggested to be involved in pathological or pathophysiological responses on brain injuries. In the present study, an involvement of ETs on activation of astrocytes in vivo was examined by using selective endothelin receptor antagonists. A stab wound injury on rat cerebral cortex increased immunoreactive ET-1 at the injured site. GFAP-positive [GFAP(+)] and vimentin-positive [Vim(+)] cells appeared at the injured site in 1 day to 2 weeks after the injury. A continuous infusion of BQ788, a selective ETB receptor antagonist, into cerebral ventricle (23 nmole/day) attenuated increase in the numbers of GFAP(+) and Vim(+) cells after the injury. FR139317, a selective ETA antagonist (23 nmole/day), slightly decreased the number of Vim(+) cells but not that of GFAP(+) cells. Increase in the number of microglia/macrophages by a stab wound injury, which was determined by Griffonia simplicifolia isolectin B4 staining, was not affected by BQ788 and FR139317. These results suggest that activation of glial ETB receptors is one of the signal cascades leading to reactive astrocytes on brain injuries.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340767     DOI: 10.1002/(sici)1098-1136(199905)26:3<268::aid-glia8>3.0.co;2-g

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  17 in total

Review 1.  Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects.

Authors:  Soheila Karimi-Abdolrezaee; Rohini Billakanti
Journal:  Mol Neurobiol       Date:  2012-06-09       Impact factor: 5.590

Review 2.  Models that matter: white matter stroke models.

Authors:  Elif G Sozmen; Jason D Hinman; S Thomas Carmichael
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

3.  Endothelin-1 stimulates expression of cyclin D1 and S-phase kinase-associated protein 2 by activating the transcription factor STAT3 in cultured rat astrocytes.

Authors:  Yutaka Koyama; Satoshi Sumie; Yasutaka Nakano; Tomoya Nagao; Shiho Tokumaru; Shotaro Michinaga
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

Review 4.  Scar-modulating treatments for central nervous system injury.

Authors:  Dingding Shen; Xiaodong Wang; Xiaosong Gu
Journal:  Neurosci Bull       Date:  2014-06-24       Impact factor: 5.203

5.  Astrocyte-derived endothelin-1 inhibits remyelination through notch activation.

Authors:  Timothy R Hammond; Ana Gadea; Jeff Dupree; Christophe Kerninon; Brahim Nait-Oumesmar; Adan Aguirre; Vittorio Gallo
Journal:  Neuron       Date:  2014-02-05       Impact factor: 17.173

Review 6.  Signaling pathways in reactive astrocytes, a genetic perspective.

Authors:  Wenfei Kang; Jean M Hébert
Journal:  Mol Neurobiol       Date:  2011-01-14       Impact factor: 5.590

7.  Ischemic model of optic nerve injury.

Authors:  George A Cioffi
Journal:  Trans Am Ophthalmol Soc       Date:  2005

8.  Notch1-STAT3-ETBR signaling axis controls reactive astrocyte proliferation after brain injury.

Authors:  Matthew D LeComte; Issei S Shimada; Casey Sherwin; Jeffrey L Spees
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

9.  Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway.

Authors:  Ana Gadea; Sergio Schinelli; Vittorio Gallo
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

10.  Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.

Authors:  Tracy J Yuen; Kory R Johnson; Veronique E Miron; Chao Zhao; Jacqueline Quandt; Marie C Harrisingh; Matthew Swire; Anna Williams; Henry F McFarland; Robin J M Franklin; Charles Ffrench-Constant
Journal:  Brain       Date:  2013-03-21       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.